PRAVEEN TYLE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PRAVEEN TYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PRAVEEN TYLE. PRAVEEN TYLE is a Senior Vice President in BAUSCH & LOMB INC ($BOL) and a EVP, R&D in LEXICON PHARMACEUTICALS, INC. ($LEXG) and a Director in EYEGATE PHARMACEUTICALS INC ($EYEG).
Address: ONE BAUSCH & LOMB PLACE ROCHESTER 14604 NY
Companies in which PRAVEEN TYLE is an Insider
BAUSCH & LOMB INC
Industry: OPHTHALMIC GOODS [3851]
Position of PRAVEEN TYLE: Senior Vice President
Holdings: 0 shares
Latest Transaction: Oct 30 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EYEGATE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PRAVEEN TYLE: Director
Holdings: 61,893 shares
Current Value: $97,791
Latest Transaction: Feb 03 2021
$EYEG Market Capitalization: $15.24M
$EYEG Previous Close: $1.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LEXICON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PRAVEEN TYLE: EVP, R&D
Holdings: 72,334 shares
Current Value: $0
Latest Transaction: Mar 02 2021
$LEXG Market Capitalization: $796343.50
$LEXG Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PRAVEEN TYLE
Sentiment: All, BOL, EYEG, LEXG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 28,690 | 0 | 57,380 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 26,600 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 7.19 | 16,560 | 119,066 | 120,791 | 137.4 K to 120.8 K (-12.06 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 28,690 | 0 | 137,351 | 108.7 K to 137.4 K (+26.40 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 108,661 | 82.1 K to 108.7 K (+32.41 %) |